Global Nanobiotechnology Market 2018-2022 | Growth Analysis and Forecast | Technavio
Jul. 04, 2018
LONDON--(BUSINESS WIRE)--Jul 4, 2018--The global nanobiotechnology market is expected to register a CAGR of nearly 9% during the period 2018-2022, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180704005221/en/
Technavio has published a new market research report on the global nanobiotechnology market from 2018-2022. (Photo: Business Wire)
A key factor driving the market’s growth is the rising R&D architecture in the pharmaceutical and biotechnology sectors. The global pharmaceutical industry is witnessing a significant increase in research funding to combat various emerging rare diseases or to explore new therapies for existing conditions. Biotechnology companies are also making increased investments in R&D. The US was the largest investor in biotechnology R&D in 2015.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio predicts an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the increasing demand for nanobiotechnology in stem cell therapy as one of the key emerging trends in the global nanobiotechnology market:
Global nanobiotechnology market: Increasing demand for nanobiotechnology in stem cell therapy
Stem cells have the potential to develop into different cell types during early life and function as internal repair systems that divide to replenish other cells in the human body. Stem cells include embryonic stem cells and non-embryonic adult stem cells that are unspecialized cells. Advances in stem cell research reveal the potential of stem cells that can change the way the diseases are perceived and treated.
“At present, thousands of clinical trials around the world involve some form of stem cell therapy as there is a lack of complete understanding of the fate of the transplanted cells and their distribution after injection. Traditionally, the monitoring of therapies is led by histological analysis that is laborious and invasive and involves multiple tissue biopsies,” says a senior analyst at Technavio for research on health and wellness.
Global nanobiotechnology market: Segmentation analysis
This market research report segments the global nanobiotechnology market into the following end-users (pharmaceutical and biotechnology industry and medical devices) and key regions (the Americas, APAC, and EMEA).
The pharmaceutical and biotechnology industry segment held the largest market share in 2017, accounting for nearly 64% of the market. This segment is expected to dominate the global market throughout the forecast period.
The Americas held the highest share of the global nanobiotechnology market in 2017, accounting for a market share of approximately 49%. The market share occupied by this region is anticipated to decrease by over 1% during 2018-2022. However, this region is anticipated to dominate the global market throughout the forecast period.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket sizing Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180704005221/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
KEYWORD: UNITED KINGDOM EUROPE
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL COMMUNICATIONS MARKETING
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 07/04/2018 11:02 AM/DISC: 07/04/2018 11:01 AM